Baillie Gifford & Co’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-19,628
Closed -$333K 275
2024
Q4
$333K Sell
19,628
-18,814
-49% -$331K ﹤0.01% 254
2024
Q3
$698K Hold
38,442
﹤0.01% 258
2024
Q2
$634K Buy
38,442
+3,783
+11% +$57.9K ﹤0.01% 262
2024
Q1
$490K Buy
34,659
+3,965
+13% +$59.8K ﹤0.01% 268
2023
Q4
$529K Buy
30,694
+3,647
+13% +$55.7K ﹤0.01% 272
2023
Q3
$413K Buy
27,047
+5,143
+23% +$91.3K ﹤0.01% 277
2023
Q2
$413K Buy
21,904
+6,437
+42% +$124K ﹤0.01% 277
2023
Q1
$299K Sell
15,467
-3,133
-17% -$63.1K ﹤0.01% 280
2022
Q4
$358K Buy
+18,600
New +$365K ﹤0.01% 289

Other funds holding HR

Baillie Gifford & Co's HR Position: Q1 2025 in Review

Baillie Gifford & Co sold out of Healthcare Realty (HR) in Q1 2025, closing a stake of 19,628 shares — an estimated $333K sold.

Baillie Gifford & Co first reported a position in HR in Q4 2022 and held it in 9 quarters. The position peaked at $698K in Q3 2024. 424 funds tracked by Wall St. Rank hold HR as of Q1 2025.

  • Baillie Gifford & Co reported no remaining Healthcare Realty position as of Q1 2025 after selling out during the quarter.
  • Baillie Gifford & Co sold 19,628 Healthcare Realty shares in Q1 2025, an estimated $333K.
  • Baillie Gifford & Co first reported a position in Healthcare Realty in Q4 2022 and held it in 9 quarters.
  • Baillie Gifford & Co's Healthcare Realty position peaked at $698K in Q3 2024.
  • 424 funds tracked by Wall St. Rank held Healthcare Realty as of Q1 2025.

Based on Baillie Gifford & Co's 13F filing for Q1 2025, filed 7 May 2025.